Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1434-9949
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis ; day:12 ; month:2 ; year:2020 ; pages:1-11
Clinical rheumatology ; (12.2.2020), 1-11
- Urheber
-
Kaine, Jeffrey
Tesser, John
Takiya, Liza
DeMasi, Ryan
Wang, Lisy
Snyder, Mark
Soma, Koshika
Fan, Haiyun
Bandi, Vara
Wollenhaupt, Jürgen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10067-020-04956-1
- URN
-
urn:nbn:de:101:1-2020050912144226388961
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kaine, Jeffrey
- Tesser, John
- Takiya, Liza
- DeMasi, Ryan
- Wang, Lisy
- Snyder, Mark
- Soma, Koshika
- Fan, Haiyun
- Bandi, Vara
- Wollenhaupt, Jürgen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Tofacitinib : JAK-Inhibitor Tofacitinib als neue orale Therapieoption für Patienten mit rheumatoider Arthritis: erste Erfahrungen aus dem Praxisalltag
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
Tofacitinib - oraler JAK-Inhibitor für die Kombinations- und Monotherapie : innovatives Wirkprinzip bei rheumatoider Arthritis
Impact of JAK inhibitors tofacitinib and baricitinib on bone turnover during steady-state and pathological conditions
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis
Granulomatöse rosazeaartiges Exanthem unter Tofacitinib
Temporary Agency Work and Firm Performance: Evidence from German Establishment-Level Panel Data
Flexibility, dual labour markets, and temporary employment: Empirical evidence from German establishment data
Career mobility of temporary workers within and across establishments: A demand-side perspective
Temporary establishment of bacteria from indoor plant leaves and soil on human skin
5 Jahre Tofacitinib bei Colitis ulcerosa
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Tofacitinib : JAK-Inhibitor Tofacitinib als neue orale Therapieoption für Patienten mit rheumatoider Arthritis: erste Erfahrungen aus dem Praxisalltag
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
Tofacitinib - oraler JAK-Inhibitor für die Kombinations- und Monotherapie : innovatives Wirkprinzip bei rheumatoider Arthritis
Impact of JAK inhibitors tofacitinib and baricitinib on bone turnover during steady-state and pathological conditions
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis
Granulomatöse rosazeaartiges Exanthem unter Tofacitinib
Temporary Agency Work and Firm Performance: Evidence from German Establishment-Level Panel Data
Flexibility, dual labour markets, and temporary employment: Empirical evidence from German establishment data
Career mobility of temporary workers within and across establishments: A demand-side perspective
Temporary establishment of bacteria from indoor plant leaves and soil on human skin
5 Jahre Tofacitinib bei Colitis ulcerosa
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Tofacitinib : JAK-Inhibitor Tofacitinib als neue orale Therapieoption für Patienten mit rheumatoider Arthritis: erste Erfahrungen aus dem Praxisalltag
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
Tofacitinib - oraler JAK-Inhibitor für die Kombinations- und Monotherapie : innovatives Wirkprinzip bei rheumatoider Arthritis
Impact of JAK inhibitors tofacitinib and baricitinib on bone turnover during steady-state and pathological conditions
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis
Granulomatöse rosazeaartiges Exanthem unter Tofacitinib
Temporary Agency Work and Firm Performance: Evidence from German Establishment-Level Panel Data
Flexibility, dual labour markets, and temporary employment: Empirical evidence from German establishment data
Career mobility of temporary workers within and across establishments: A demand-side perspective
Temporary establishment of bacteria from indoor plant leaves and soil on human skin